252 related articles for article (PubMed ID: 3100656)
1. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
[TBL] [Abstract][Full Text] [Related]
2. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
3. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS.
Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M
Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784
[TBL] [Abstract][Full Text] [Related]
4. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
5. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
6. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
[TBL] [Abstract][Full Text] [Related]
7. Langerhans' cells are an actual site of HIV-1 replication.
Rappersberger K; Gartner S; Schenk P; Stingl G; Groh V; Tschachler E; Mann DL; Wolff K; Konrad K; Popovic M
Intervirology; 1988; 29(4):185-94. PubMed ID: 3182233
[TBL] [Abstract][Full Text] [Related]
8. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
[TBL] [Abstract][Full Text] [Related]
12. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.
Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M
JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587
[TBL] [Abstract][Full Text] [Related]
13. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
15. AIDS and Langerhans cells: CD4 antigenic site density modification evidenced by single-cell immunogold labeling.
Gielen V; Schmitt D; Dezutter-Dambuyant C; Thivolet J
Reg Immunol; 1989; 2(1):7-13. PubMed ID: 2641919
[TBL] [Abstract][Full Text] [Related]
16. LAV/HTLV-III infection in children of African origin: experience in Belgium.
Jonckheer T; Levy J; Van de Perre P; Thiry L; Henrivaux P; Sacré JP; Schepens G; Mees N; Dab I; Taelman H
Eur J Pediatr; 1986 Dec; 145(6):511-6. PubMed ID: 2949977
[TBL] [Abstract][Full Text] [Related]
17. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719
[TBL] [Abstract][Full Text] [Related]
18. Evidence for HTLV-III/LAV expression by primary cultures of T8 cells.
Fouchard M; Reveil B; Mbayo K; Lurhuma A; Sarin PS; Gallo RC; Zagury D
Int J Cancer; 1986 Nov; 38(5):657-9. PubMed ID: 2945790
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV.
Kanitakis J; Marchand C; Su H; Thivolet J; Zambruno G; Schmitt D; Gazzolo L
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):293-302. PubMed ID: 2471543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]